D'Aleo Giangaetano, Cammaroto Simona, Rifici Carmela, Marra Giuseppe, Sessa Edoardo, Bramanti Placido, Di Bella Paolo
IRCCS Centro Neurolesi Bonino-Pulejo, Messina, Italy.
Funct Neurol. 2007 Apr-Jun;22(2):81-8.
Since 1977 several cases of hallucinations after abrupt withdrawal of oral baclofen have been described. There are no reports of hallucinations after gradual withdrawal of oral baclofen. No one has ever described visual hallucinations after abrupt interruption of intrathecal baclofen therapy. We describe five personally observed cases of visual hallucinations occurring after sudden interruption of baclofen (in two of these cases, intrathecal baclofen) therapy. The patients were immediately submitted to routine EEG, visual evoked potentials and standard brain magnetic resonance imaging (MRI). A few days later they also underwent polysomnography, fundus oculi examination and brain MRI of the temporal lobe. All these examinations were normal. We hypothesise that these symptoms could be due to biochemical and molecular changes, chiefly in glutamatergic n-methyl-d-aspartate, GABA-A, and GABA-B receptor response, leading to increased excitability and spontaneous activity as a result of chronic use of baclofen.
自1977年以来,已有多例关于口服巴氯芬突然停药后出现幻觉的病例报道。但没有关于口服巴氯芬逐渐停药后出现幻觉的报道。也从未有人描述过鞘内注射巴氯芬治疗突然中断后出现视幻觉的情况。我们描述了5例亲自观察到的巴氯芬(其中2例为鞘内注射巴氯芬)治疗突然中断后出现视幻觉的病例。这些患者立即接受了常规脑电图、视觉诱发电位和标准脑磁共振成像(MRI)检查。几天后,他们还接受了多导睡眠图检查、眼底检查和颞叶脑MRI检查。所有这些检查均正常。我们推测这些症状可能是由于生化和分子变化引起的,主要是谷氨酸能N-甲基-D-天冬氨酸、GABA-A和GABA-B受体反应,长期使用巴氯芬导致兴奋性增加和自发活动增强。